ORSTED.CO vs. NOVO-B.CO
Compare and contrast key facts about Ørsted A/S (ORSTED.CO) and Novo Nordisk A/S (NOVO-B.CO).
Performance
ORSTED.CO vs. NOVO-B.CO - Performance Comparison
Loading graphics...
ORSTED.CO vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ORSTED.CO Ørsted A/S | 29.34% | -32.10% | -13.38% | -39.38% | -23.30% | -32.05% | 83.19% | 61.34% | 31.69% | 29.59% |
NOVO-B.CO Novo Nordisk A/S | -24.65% | -46.40% | -9.59% | 50.74% | 29.53% | 75.62% | 12.77% | 32.92% | -8.60% | 35.35% |
Returns By Period
In the year-to-date period, ORSTED.CO achieves a 29.34% return, which is significantly higher than NOVO-B.CO's -24.65% return.
ORSTED.CO
- 1D
- 1.44%
- 1M
- 4.98%
- YTD
- 29.34%
- 6M
- 35.26%
- 1Y
- -4.97%
- 3Y*
- -21.27%
- 5Y*
- -22.02%
- 10Y*
- —
NOVO-B.CO
- 1D
- 2.60%
- 1M
- 5.86%
- YTD
- -24.65%
- 6M
- -33.97%
- 1Y
- -46.86%
- 3Y*
- -22.16%
- 5Y*
- 4.16%
- 10Y*
- 5.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ORSTED.CO vs. NOVO-B.CO — Risk / Return Rank
ORSTED.CO
NOVO-B.CO
ORSTED.CO vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ørsted A/S (ORSTED.CO) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ORSTED.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.09 | -0.88 | +0.79 |
Sortino ratioReturn per unit of downside risk | 0.25 | -1.12 | +1.37 |
Omega ratioGain probability vs. loss probability | 1.04 | 0.84 | +0.20 |
Calmar ratioReturn relative to maximum drawdown | -0.18 | -0.87 | +0.68 |
Martin ratioReturn relative to average drawdown | -0.33 | -1.48 | +1.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ORSTED.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.09 | -0.88 | +0.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | 0.11 | -0.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.16 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.06 | 0.51 | -0.45 |
Correlation
The correlation between ORSTED.CO and NOVO-B.CO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ORSTED.CO vs. NOVO-B.CO - Dividend Comparison
ORSTED.CO has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.94%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ORSTED.CO Ørsted A/S | 0.00% | 0.00% | 0.00% | 3.61% | 1.98% | 1.38% | 0.84% | 1.42% | 2.07% | 1.77% | 0.00% | 0.00% |
NOVO-B.CO Novo Nordisk A/S | 4.94% | 3.58% | 1.59% | 1.01% | 1.19% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% |
Drawdowns
ORSTED.CO vs. NOVO-B.CO - Drawdown Comparison
The maximum ORSTED.CO drawdown since its inception was -86.13%, which is greater than NOVO-B.CO's maximum drawdown of -76.75%. Use the drawdown chart below to compare losses from any high point for ORSTED.CO and NOVO-B.CO.
Loading graphics...
Drawdown Indicators
| ORSTED.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.13% | -76.75% | -9.38% |
Max Drawdown (1Y)Largest decline over 1 year | -44.47% | -54.94% | +10.47% |
Max Drawdown (5Y)Largest decline over 5 years | -82.30% | -76.75% | -5.55% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.75% | — |
Current DrawdownCurrent decline from peak | -77.94% | -75.38% | -2.56% |
Average DrawdownAverage peak-to-trough decline | -33.03% | -15.80% | -17.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.21% | 32.14% | -7.93% |
Volatility
ORSTED.CO vs. NOVO-B.CO - Volatility Comparison
Ørsted A/S (ORSTED.CO) has a higher volatility of 11.36% compared to Novo Nordisk A/S (NOVO-B.CO) at 9.07%. This indicates that ORSTED.CO's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ORSTED.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.36% | 9.07% | +2.29% |
Volatility (6M)Calculated over the trailing 6-month period | 28.51% | 40.80% | -12.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.19% | 55.40% | -1.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.81% | 38.25% | +7.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.51% | 32.32% | +5.19% |
Financials
ORSTED.CO vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Ørsted A/S and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities